Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

oligofructose-enriched inulin

A mixture of non-digestible carbohydrates, containing the fermentable plant fructans oligosaccharide and inulin, with potential prebiotic activity. Resisting hydrolysis by intestinal digestive enzymes, inulin and oligofructose serve as growth media and energy substrates for bifidobacteria in the colon; beneficial colonic commensal bacteria such as bifidobacteria may inhibit the colonization of the intestine by pathogenic bacteria and have been inplicated to inhibit colon carcinogenesis. Oligofructose-enriched inulin may be administered in combination with probiotic bifidobacteria. In addition, this agent may promote the absorption of calcium and magnesium from the gastrointestinal tract.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:Synergy 1
US brand name:Beneo Synergy 1
Foreign brand name:Beneo Synergy 1
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search